查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387409

In Silico药物研发市场报告：2030 年趋势、预测与竞争分析

In-Silico Drug Discovery Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

In Silico药物研发的趋势和预测

到 2030 年，全球In Silico药物研发市场预计将达到 54.5 亿美元，2024 年至 2030 年年复合成长率为 10.2%。该市场的主要驱动因素是越来越多地关注减少用药错误、在药物研发中越来越多地采用云端基础的应用程式以及计算生物学的持续进步。全球In Silico药物研发市场的未来前景广阔，CRO、製药业和学术/研究机构市场存在商机。

In Silico药物研发市场洞察

Lucintel 预测，由于药物研发过程中越来越多地采用虚拟筛选和目标发现，软体即服务预计将在预测期内实现最高成长。

製药业仍将是该市场中最大的部分，因为In Silico药物研发有助于製药公司缩短开发新药的时间和成本。

由于生物製药公司研发支出增加、大型製药企业的存在以及大量患有各种慢性和感染疾病的患者，北美在预测期内将继续成为最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球In Silico药物研发市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球In Silico药物研发市场趋势（2018-2023）和预测（2024-2030）
  • 按类型分類的全球In Silico药物研发市场
    • SaaS（Software as a Service）
    • CaaS（Consultancy as a Service）
    • 软体
  • 按标靶治疗领域分類的全球In Silico药物研发市场
    • 人类免疫力缺乏病毒（HIV）
    • 感染疾病
    • 代谢紊乱
    • 精神障碍
    • 肌肉骨骼疾病
    • 神经系统疾病
    • 肿瘤性疾病
    • 呼吸系统疾病
    • 其他的
  • 按工作流程分類的全球In Silico药物研发市场
    • 发现
    • 目标识别
    • 反向对接
    • 生物资讯学
    • 蛋白质结构预测
    • 目标检验
    • 先导化合物发现
    • 药效基团
    • 其他的
  • 按最终用途分類的全球In Silico药物研发市场
    • CRO
    • 製药业
    • 学术/研究机构
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球In Silico药物研发市场
  • 北美电脑In Silico药物研发市场
  • 欧洲In Silico药物研发市场
  • 亚太地区In Silico药物研发市场
  • 其他地区的In Silico药物研发市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球In Silico药物研发市场成长机会（按类型）
    • 按标靶治疗领域分類的全球In Silico药物研发市场成长机会
    • 按工作流程分類的全球In Silico药物研发市场成长机会
    • 全球In Silico药物研发市场成长机会（按最终用途）
    • 全球In Silico药物研发市场成长机会（按地区）
  • 全球In Silico药物研发市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球In Silico药物研发市场的能力
    • 全球In Silico药物研发市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Curia
  • Certara
  • Charles River Laboratories
  • Chemical Computing
  • GenScript
  • Sygnature Discovery
  • Abzena
简介目录

In-Silico Drug Discovery Trends and Forecast

The future of the global in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets. The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.

A more than 150-page report is developed to help in your business decisions.

In-Silico Drug Discovery by Segment

The study includes a forecast for the global in-silico drug discovery by type, target therapeutic area, workflow, end use, and region.

In-Silico Drug Discovery Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Software as a Service
  • Consultancy as a Service
  • Software

In-Silico Drug Discovery Market by Target Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:

  • Human Immunodeficiency Virus (HIV)
  • Infectious Diseases
  • Metabolic Disorders
  • Mental Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others

In-Silico Drug Discovery Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Discovery
  • Target Identification
  • Reverse Docking
  • Bioinformatics
  • Protein Structure Prediction
  • Target Validation
  • Lead Discovery
  • Pharmacophore
  • Others

In-Silico Drug Discovery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Contract Research Organizations
  • Pharmaceutical Industry
  • Academic & Research Institutes
  • Others

In-Silico Drug Discovery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of In-Silico Drug Discovery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-silico drug discovery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-silico drug discovery companies profiled in this report include-

  • Curia
  • Certara
  • Charles River Laboratories
  • Chemical Computing
  • GenScript
  • Sygnature Discovery
  • Abzena

In-Silico Drug Discovery Market Insights

Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.

Within this market, pharmaceutical industry will remain the largest segment due as in-silico drug discovery helps the pharmaceutical companies to reduce the time and cost of developing new drugs.

North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.

Features of the Global In-Silico Drug Discovery Market

Market Size Estimates: In-silico drug discovery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: In-silico drug discovery market size by various segments, such as by type, target therapeutic area, workflow, end use, and region in terms of value ($B).

Regional Analysis: In-silico drug discovery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, target therapeutic areas, workflow, end uses, and regions for the in-silico drug discovery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-silico drug discovery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the in-silico drug discovery market size?

Answer: The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030.

Q2. What is the growth forecast for in-silico drug discovery market?

Answer: The global in-silico drug discovery market is expected to grow with a CAGR of 10.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the in-silico drug discovery market?

Answer: The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.

Q4. What are the major segments for in-silico drug discovery market?

Answer: The future of the in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets.

Q5. Who are the key in-silico drug discovery market companies?

Answer: Some of the key in-silico drug discovery companies are as follows:

  • Curia
  • Certara
  • Charles River Laboratories
  • Chemical Computing
  • GenScript
  • Sygnature Discovery
  • Abzena

Q6. Which in-silico drug discovery market segment will be the largest in future?

Answer: Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.

Q7. In in-silico drug discovery market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the in-silico drug discovery market by type (software as a service, consultancy as a service, and software), target therapeutic area (human immunodeficiency virus (HIV), infectious diseases, metabolic disorders, mental disorders, musculoskeletal disorders, neurological disorders, oncological disorders, respiratory disorders, and others), workflow (discovery, target identification, reverse docking, bioinformatics, protein structure prediction, target validation, lead discovery, pharmacophore, and others), end use (contract research organizations, pharmaceutical industry, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global In-Silico Drug Discovery Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global In-Silico Drug Discovery Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global In-Silico Drug Discovery Market by Type
    • 3.3.1: Software as a service
    • 3.3.2: Consultancy as a service
    • 3.3.3: Software
  • 3.4: Global In-Silico Drug Discovery Market by Target Therapeutic Area
    • 3.4.1: Human Immunodeficiency Virus (HIV)
    • 3.4.2: Infectious diseases
    • 3.4.3: Metabolic disorders
    • 3.4.4: Mental disorders
    • 3.4.5: Musculoskeletal disorders
    • 3.4.6: Neurological disorders
    • 3.4.7: Oncological disorders
    • 3.4.8: Respiratory disorders
    • 3.4.9: Others
  • 3.5: Global In-Silico Drug Discovery Market by Workflow
    • 3.5.1: Discovery
    • 3.5.2: Target identification
    • 3.5.3: Reverse docking
    • 3.5.4: Bioinformatics
    • 3.5.5: Protein structure prediction
    • 3.5.6: Target validation
    • 3.5.7: Lead discovery
    • 3.5.8: Pharmacophore
    • 3.5.9: Others
  • 3.6: Global In-Silico Drug Discovery Market by End Use
    • 3.6.1: Contract research organizations
    • 3.6.2: Pharmaceutical industry
    • 3.6.3: Academic & research institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global In-Silico Drug Discovery Market by Region
  • 4.2: North American In-Silico Drug Discovery Market
    • 4.2.2: North American In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others
  • 4.3: European In-Silico Drug Discovery Market
    • 4.3.1: European In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
    • 4.3.2: European In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others
  • 4.4: APAC In-Silico Drug Discovery Market
    • 4.4.1: APAC In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
    • 4.4.2: APAC In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others
  • 4.5: ROW In-Silico Drug Discovery Market
    • 4.5.1: ROW In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
    • 4.5.2: ROW In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global In-Silico Drug Discovery Market by Type
    • 6.1.2: Growth Opportunities for the Global In-Silico Drug Discovery Market by Target Therapeutic Area
    • 6.1.3: Growth Opportunities for the Global In-Silico Drug Discovery Market by Workflow
    • 6.1.4: Growth Opportunities for the Global In-Silico Drug Discovery Market by End Use
    • 6.1.5: Growth Opportunities for the Global In-Silico Drug Discovery Market by Region
  • 6.2: Emerging Trends in the Global In-Silico Drug Discovery Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global In-Silico Drug Discovery Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In-Silico Drug Discovery Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Curia
  • 7.2: Certara
  • 7.3: Charles River Laboratories
  • 7.4: Chemical Computing
  • 7.5: GenScript
  • 7.6: Sygnature Discovery
  • 7.7: Abzena